Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BLFS BioLife Solutions, Inc. daily Stock Chart
BLFS [NASD]
BioLife Solutions, Inc.
Healthcare | Medical Instruments & Supplies | USA
financial highlights | statements
Index- P/E287.27 EPS (ttm)0.04 Insider Own14.70% Shs Outstand18.16M Perf Week1.04%
Market Cap229.54M Forward P/E48.06 EPS next Y0.26 Insider Trans-6.05% Shs Float13.01M Perf Month19.25%
Income1.40M PEG- EPS next Q0.05 Inst Own42.80% Short Float3.28% Perf Quarter-4.02%
Sales17.40M P/S13.19 EPS this Y62.20% Inst Trans0.22% Short Ratio2.74 Perf Half Y-37.30%
Book/sh2.54 P/B4.98 EPS next Y61.35% ROA6.20% Target Price20.00 Perf Year124.51%
Cash/sh- P/C- EPS next 5Y- ROE6.80% 52W Range4.63 - 26.35 Perf YTD5.07%
Dividend- P/FCF99.80 EPS past 5Y9.20% ROI-10.50% 52W High-52.03% Beta1.39
Dividend %- Quick Ratio16.90 Sales past 5Y14.20% Gross Margin66.70% 52W Low173.00% ATR0.85
Employees35 Current Ratio18.30 Sales Q/Q76.70% Oper. Margin13.70% RSI (14)57.79 Volatility5.19% 8.09%
OptionableNo Debt/Eq0.00 EPS Q/Q251.60% Profit Margin8.20% Rel Volume0.85 Prev Close12.64
ShortableYes LT Debt/Eq0.00 EarningsFeb 07 AMC Payout0.00% Avg Volume156.03K Price12.64
Recom- SMA208.81% SMA5010.60% SMA200-6.94% Volume0 Change0.00%
Nov-10-17Reiterated Maxim Group Buy $7 → $8
Sep-19-17Reiterated Maxim Group Buy $6 → $7
Jul-05-17Upgrade Janney Neutral → Buy $5
Mar-10-17Reiterated Maxim Group Buy $3 → $4
Jan-19-17Initiated Maxim Group Buy $3
Jan-11-19 08:53AM  Medical Products Industry Gathering Steam: 3 Stocks to Buy Zacks
Dec-11-18 08:00AM  Consolidated Research: 2018 Summary Expectations for Enbridge Energy Partners, Sprouts Farmers Market, BioLife Solutions, PagSeguro Digital, NutriSystem, and Employers Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-07-18 02:20PM  Edited Transcript of BLFS earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -7.07%
Nov-27-18 08:00AM  BioLife Solutions Completes Redemption of Series A Preferred Stock PR Newswire
Nov-13-18 08:00AM  BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences PR Newswire
Nov-08-18 04:05PM  BioLife Solutions Announces Third Quarter 2018 Financial Results PR Newswire
Nov-05-18 08:08AM  BioLife (BLFS) to Report Q3 Earnings: What's in the Cards? Zacks
08:00AM  SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis PR Newswire
Nov-01-18 08:00AM  BioLife Solutions to Report Third Quarter 2018 Financial Results and Provide Business Update on November 8, 2018 PR Newswire
Oct-18-18 07:40AM  Market Trends Toward New Normal in Rambus, GMS, Advanced Energy Industries, AZZ, BioLife Solutions, and Spartan Motors Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-03-18 06:57AM  BioLife Solutions Sees Hammer Chart Pattern: Time to Buy? Zacks -15.87%
Oct-01-18 08:00AM  BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year PR Newswire
Sep-27-18 09:30AM  Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-05-18 04:31PM  Local bioscience firm nets $5 million investment American City Business Journals -14.12%
08:00AM  BioLife Solutions Increases Ownership in SAVSU Technologies to 44% with $5 Million Investment PR Newswire
Sep-04-18 09:55AM  The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast Zacks
Aug-31-18 08:32AM  Trump's Approval Rating Buoy Wall Street: 4 Top Gainers Zacks
Aug-30-18 08:45AM  Canopy Growth (CGC) Jumps: Stock Rises 7.4% Zacks
Aug-29-18 09:08AM  Bull Run to Continue in Rest of 2018: 5 Terrific Growth Picks Zacks
Aug-24-18 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel New Research Emphasizes Economic Growth GlobeNewswire
Aug-22-18 08:31AM  Medtronic (MDT) Surges: Stock Moves 5.7% Higher Zacks
08:00AM  BioLife Solutions to Ring NASDAQ Closing Bell on August 29, 2018 PR Newswire
Aug-21-18 08:33AM  PetIQ (PETQ) Catches Eye: Stock Jumps 9.1% Zacks +16.00%
Aug-10-18 11:06AM  Edited Transcript of BLFS earnings conference call or presentation 9-Aug-18 2:00pm GMT Thomson Reuters StreetEvents
Aug-09-18 08:15AM  BioLife Solutions Announces Second Quarter 2018 Financial Results PR Newswire
08:05AM  Casdin Capital Invests $20 Million in BioLife Solutions to Support Strategic Growth Opportunities PR Newswire
08:00AM  BioLife Solutions, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-18 09:58AM  Top Ranked Momentum Stocks to Buy for August 6th Zacks
08:00AM  BioLife Solutions to Present and Exhibit at Fall Investor and Cell & Gene Therapy Conferences PR Newswire
Aug-03-18 07:20AM  Top Ranked Momentum Stocks to Buy for August 3rd Zacks
Aug-02-18 08:00AM  BioLife Solutions to Report Second Quarter 2018 Financial Results and Provide Business Update on August 9, 2018 PR Newswire
Jul-31-18 08:03AM  SAVSU Technologies Awarded New Patent for Cold Chain Technologies Used in Cell and Gene Therapies PR Newswire +7.44%
Jul-20-18 09:30AM  Has BioLife Solutions (BLFS) Outpaced Other Medical Stocks This Year? Zacks
Jul-17-18 08:51AM  Zacks.com featured highlights include: CNX, Radcom, BioLife, Momo and Atlas Air Zacks
Jul-16-18 12:44PM  Improve Your Portfolio With These 5 Top Profitable Stocks InvestorPlace +5.91%
Jul-10-18 09:37AM  Top Ranked Momentum Stocks to Buy for July 10th Zacks
Jul-09-18 08:00AM  Sandler Capital Funds to Increase Shareholding in BioLife Solutions PR Newswire
Jul-05-18 09:51AM  Top Ranked Momentum Stocks to Buy for July 5th Zacks
09:15AM  A Short but Not So Sweet Session Zacks
Jul-03-18 10:33AM  Can The Uptrend Continue for BioLife Solutions (BLFS)? Zacks +11.41%
Jul-02-18 08:00AM  BioLife Solutions Reports Second Quarter 2018 Preliminary Revenue of $5.2 Million, up 103% Year-over-Year and 36% Sequentially PR Newswire +31.38%
Jun-20-18 07:55AM  Consolidated Research: 2018 Summary Expectations for Xenia Hotels & Resorts, GMS, Schnitzer Steel Industries, BioLife Solutions, Pinnacle Foods, and Ennis Fundamental Analysis, Key Performance Indications GlobeNewswire
Jun-11-18 12:49PM  BioLife Solutions to Join Russell Microcap® Index PR Newswire
May-29-18 08:00AM  BioLife Solutions to Present at the 2018 BIO International Convention PR Newswire +5.47%
May-17-18 10:05AM  BioLife Solutions (BLFS) Shares March Higher, Can It Continue? Zacks
08:00AM  BioLife Solutions Announces Partial Redemption of Series A Preferred Stock PR Newswire
May-16-18 08:00AM  BioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative Medicine Cold Chain Opportunities PR Newswire
07:00AM  Blog Exposure - Milestone Scientific Announced Deal with Leading Midwestern Distributor for CompuFlo(R) Epidural System Sale in the US ACCESSWIRE
May-11-18 04:36PM  Edited Transcript of BLFS earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-10-18 04:05PM  BioLife Solutions Announces First Quarter 2018 Financial Results PR Newswire
May-03-18 08:00AM  BioLife Solutions to Report First Quarter 2018 Financial Results and Provide Business Update on May 10, 2018 PR Newswire
Apr-30-18 08:00AM  BioLife Solutions Receives $2.6 Million from Exercise of Warrants PR Newswire
Apr-26-18 08:15AM  Detailed Research: Economic Perspectives on Natural Health Trends, BioLife Solutions, The Chefs' Warehouse, Vocera Communications, GMS, and Enable Midstream Partners, LP What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-09-18 08:00AM  Casdin Capital to Become Shareholder in BioLife Solutions PR Newswire
Apr-02-18 08:00AM  BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially PR Newswire +20.47%
Mar-26-18 08:00AM  BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies PR Newswire
Mar-13-18 08:00AM  BioLife Solutions CryoStor® Cell Freeze Media Highlighted in Mayo Clinic/MD Anderson Journal Article on Preservation of Patient-Derived Xenografts for Cancer Research PR Newswire
Mar-09-18 12:42PM  Edited Transcript of BLFS earnings conference call or presentation 8-Mar-18 9:00pm GMT Thomson Reuters StreetEvents -6.51%
Mar-08-18 04:05PM  BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results PR Newswire
12:00PM  BioLife Solutions, Inc. to Host Earnings Call ACCESSWIRE
10:19AM  When Will BioLife Solutions Inc (NASDAQ:BLFS) Breakeven? Simply Wall St.
Mar-01-18 04:15PM  BioLife Solutions to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Business Update on March 8, 2018 PR Newswire
Feb-28-18 08:30AM  New Research Coverage Highlights PROS, BioLife Solutions, Home BancShares, Revance Therapeutics, HomeStreet, and Ennis Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Feb-13-18 08:00AM  BioLife Solutions Executes OEM Agreement with MilliporeSigma PR Newswire
Jan-23-18 09:52AM  BioLife Solutions Announces SAVSU Alliance with World Courier PR Newswire
Jan-18-18 06:30AM  SAVSU Technologies and BioLife Solutions Increase evo® Intellectual Property Estate with Notice of Allowance of New Patent for Cold Chain Technologies PR Newswire
Jan-16-18 06:30AM  BioLife Solutions to Attend and Present at Upcoming Investor & Scientific Conferences PR Newswire
Jan-04-18 04:40PM  Is There An Opportunity With BioLife Solutions Incs (NASDAQ:BLFS) 21.60% Undervaluation? Simply Wall St.
06:30AM  BioLife Solutions Announces Preliminary 2017 Revenue Increase of 34% to $11 Million PR Newswire
Jan-02-18 07:45AM  Detailed Research: Economic Perspectives on Advanced Energy Industries, News Corporation, Ethan Allen Interiors, Inogen, PROS, and BioLife Solutions What Drives Growth in Today's Competitive Landscape GlobeNewswire
Dec-25-17 09:30AM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-15-17 07:40AM  Wired News BioLifes CryoStor(R) Freeze Media and HypoThermosol® Cell Storage Adopted by Iovance Biotherapeutics ACCESSWIRE
Dec-13-17 07:54AM  Should BioLife Solutions Incs (undefined:BLFS) Earnings Decline In Recent Times Worry You? Simply Wall St.
06:30AM  BioLife Solutions Executes Supply Agreement with Iovance Biotherapeutics PR Newswire
Dec-01-17 09:02AM  The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx Zacks
Nov-29-17 06:30AM  BioLife Solutions Executes Additional Long-Term Supply Agreement with Leading T Cell Therapy Customer PR Newswire
Nov-28-17 07:02AM  Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences Zacks
Nov-27-17 09:12AM  New Analyst Coverage Puts the Spotlight on These 5 Stocks Zacks
Nov-13-17 03:18PM  Edited Transcript of BLFS earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents +5.08%
Nov-09-17 04:05PM  BioLife Solutions Announces Third Quarter 2017 Financial Results PR Newswire
Nov-06-17 11:11AM  ETFs with exposure to BioLife Solutions, Inc. : November 6, 2017 Capital Cube
Nov-02-17 06:30AM  BioLife Solutions to Report Third Quarter 2017 Financial Results and Provide Business Update on November 9, 2017 PR Newswire
Oct-31-17 06:30AM  BioLife Solutions and SAVSU Providing Enhanced Cold Chain Technologies for 8 UCSF Clinical Trials of Treg Cell Therapies PR Newswire
Oct-30-17 06:30AM  BioLife Solutions Receives $1.9 Million from Exercise of Warrants PR Newswire
Oct-23-17 10:24AM  ETFs with exposure to BioLife Solutions, Inc. : October 23, 2017 Capital Cube
Oct-19-17 06:30AM  BioLife Solutions Customer Kite Pharma Receives FDA Approval for Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy PR Newswire
Oct-18-17 02:31PM  Should You Buy BioLife Solutions Inc (BLFS) Now? Simply Wall St. +5.72%
06:30AM  BioLife Solutions to Present at Upcoming Investor Conferences PR Newswire
Oct-11-17 11:14AM  ETFs with exposure to BioLife Solutions, Inc. : October 11, 2017 Capital Cube
Sep-28-17 10:10AM  ETFs with exposure to BioLife Solutions, Inc. : September 28, 2017 Capital Cube
Sep-27-17 09:01AM  BioLife Solutions, Inc. :BLFS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017 Capital Cube
Sep-19-17 06:30AM  BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin PR Newswire
Sep-07-17 06:30AM  BioLife Solutions to Present at September Investment Conferences PR Newswire
Sep-05-17 06:58AM  Novartis CAR-T therapy was the first approved in U.S. heres how to invest in the space MarketWatch
Aug-11-17 06:43PM  Edited Transcript of BLFS earnings conference call or presentation 10-Aug-17 8:30pm GMT Thomson Reuters StreetEvents +5.56%
Aug-10-17 04:05PM  BioLife Solutions Announces Second Quarter 2017 Financial Results PR Newswire
12:30PM  Investor Network: BIOLIFE SOLUTIONS INC to Host Earnings Call ACCESSWIRE
Aug-03-17 06:30AM  BioLife Solutions to Report Second Quarter 2017 Financial Results and Provide Business Update on August 10, 2017 PR Newswire
Aug-02-17 07:30AM  Featured Company News BioLife Solutions Executes Supply Agreement with Celyad for CryoStor(R) Use in Natural Killer Receptor based T-Cell (NKR-T) Platform ACCESSWIRE +6.61%
Jul-31-17 06:30AM  BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers PR Newswire
BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 for cryopreservation of stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services; and contract aseptic manufacturing formulation, filling, and finishing services for liquid media products. It markets its products to the regenerative medicine, bio-banking, and drug discovery markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, and hair transplant centers, as well as suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. The company markets and sells its products directly using its sales force, as well as through biolifesolutions.com; and through various regional distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DE GREEF RODERICKChief Financial OfficerMay 29Option Exercise1.6415,00024,60029,583May 29 06:30 PM
DE GREEF RODERICKChief Financial OfficerMay 29Sale9.6515,000144,75014,583May 29 06:30 PM
DE GREEF RODERICKChief Financial OfficerMay 25Option Exercise1.6410,00016,40024,583May 29 06:30 PM
DE GREEF RODERICKChief Financial OfficerMay 25Sale9.3510,00093,50014,583May 29 06:30 PM
DE GREEF RODERICKChief Financial OfficerJan 17Option Exercise1.8110,00018,09924,583Jan 17 08:31 PM
DE GREEF RODERICKChief Financial OfficerJan 17Sale12.4910,000124,90014,583Jan 17 08:31 PM
Berard ToddVice President, MarketingJan 15Option Exercise2.063,0006,18037,583Jan 17 08:31 PM
Rice MichaelPresident & CEOJan 15Option Exercise1.2614,78118,624154,298Jan 17 08:31 PM
Rice MichaelPresident & CEOJan 15Sale12.1414,781179,441139,517Jan 17 08:31 PM
Berard ToddVice President, MarketingJan 15Sale12.123,00036,36034,583Jan 17 08:31 PM
COHEN RAYMOND WDirectorDec 20Option Exercise1.265,3576,75538,388Dec 26 05:21 PM
DE GREEF RODERICKChief Financial OfficerDec 19Option Exercise1.8110,00018,09924,583Dec 21 04:03 PM
DE GREEF RODERICKChief Financial OfficerDec 19Sale10.6710,000106,70014,583Dec 21 04:03 PM
Rice MichaelPresident & CEODec 13Option Exercise1.2614,78118,624154,298Dec 14 04:02 PM
Hinson Andrew GDirectorDec 13Sale12.054,00048,20045,747Dec 14 04:02 PM
Rice MichaelPresident & CEODec 13Sale11.4414,781169,095139,517Dec 14 04:02 PM
DE GREEF RODERICKChief Financial OfficerOct 21Option Exercise1.8110,00018,09924,583Nov 23 06:56 PM
DE GREEF RODERICKChief Financial OfficerOct 21Sale10.0010,000100,00014,583Nov 23 06:56 PM
DE GREEF RODERICKChief Financial OfficerOct 17Option Exercise1.8110,00018,09924,583Oct 19 04:30 PM
DE GREEF RODERICKChief Financial OfficerOct 17Sale12.9510,000129,50014,583Oct 19 04:30 PM
Rice MichaelPresident & CEOOct 01Option Exercise1.2612,54015,800152,057Oct 02 04:02 PM
Rice MichaelPresident & CEOOct 01Sale17.5712,540220,328139,517Oct 02 04:02 PM
Berard ToddVice President, MarketingSep 21Option Exercise2.063,0006,18037,583Sep 25 04:54 PM
Berard ToddVice President, MarketingSep 21Sale17.233,00051,69034,583Sep 25 04:54 PM
DE GREEF RODERICKChief Financial OfficerSep 19Option Exercise1.8110,00018,09924,583Sep 21 05:00 PM
DE GREEF RODERICKChief Financial OfficerSep 19Sale17.2210,000172,20014,583Sep 21 05:00 PM
Rice MichaelPresident & CEOSep 05Option Exercise1.2612,54015,800152,057Sep 07 04:01 PM
Rice MichaelPresident & CEOSep 05Sale21.5512,540270,178139,517Sep 07 04:01 PM
Schick Joseph CDirectorAug 24Sale25.964,765123,68910,000Aug 24 05:37 PM
COHEN RAYMOND WDirectorAug 21Sale23.6810,000236,80033,031Aug 22 08:28 PM
Rice MichaelPresident & CEOAug 16Option Exercise1.1212,54014,045152,057Aug 16 06:02 PM
DE GREEF RODERICKChief Financial OfficerAug 16Option Exercise1.8110,00018,09924,583Aug 17 05:00 PM
DE GREEF RODERICKChief Financial OfficerAug 16Sale19.1010,000191,00014,583Aug 17 05:00 PM
Rice MichaelPresident & CEOAug 16Sale19.5012,540244,530139,517Aug 16 06:02 PM
COHEN RAYMOND WDirectorAug 13Sale19.7010,000197,00043,031Aug 14 06:54 PM
DE GREEF RODERICKChief Financial OfficerJul 18Option Exercise1.8110,00018,09924,583Jul 20 05:09 PM
DE GREEF RODERICKChief Financial OfficerJul 18Sale20.0010,000200,00014,583Jul 20 05:09 PM
Rice MichaelPresident & CEOJul 16Option Exercise1.1212,54014,045152,057Jul 17 06:08 PM
Rice MichaelPresident & CEOJul 16Sale19.9012,540249,546139,517Jul 17 06:08 PM
VILLIGER WALTER10% OwnerJul 09Sale11.37214,2862,436,4323,533,217Jul 09 05:57 PM
GIRSCHWEILER THOMASDirectorJul 09Sale11.37285,7143,248,5681,513,963Jul 09 05:56 PM
Rice MichaelPresident & CEOJun 18Option Exercise1.1212,54014,045152,057Jun 20 09:04 PM
Rice MichaelPresident & CEOJun 18Sale12.8912,540161,641139,517Jun 20 09:04 PM
Hinson Andrew GDirectorJun 13Option Exercise1.3321,42828,52159,747Jun 14 04:34 PM
Hinson Andrew GDirectorJun 13Sale11.2510,000112,50049,474Jun 14 04:34 PM
Schick Joseph CDirectorJun 01Sale10.076,85869,05914,765Jun 05 08:07 PM
DE GREEF RODERICKChief Financial OfficerMay 31Option Exercise1.6410,00016,40024,583Jun 04 05:58 PM
DE GREEF RODERICKChief Financial OfficerMay 31Sale10.4410,000104,40014,583Jun 04 05:58 PM
COHEN RAYMOND WDirectorMay 30Sale10.1510,000101,50053,031Jun 01 05:29 PM
Rice MichaelPresident & CEOMay 15Option Exercise1.1212,54014,045152,057May 16 07:54 PM
Rice MichaelPresident & CEOMay 15Sale8.6512,540108,471139,517May 16 07:54 PM
Rice MichaelPresident & CEOApr 17Option Exercise1.125,9006,608145,417Apr 18 04:22 PM
Rice MichaelPresident & CEOApr 17Sale7.225,90042,598139,517Apr 18 04:22 PM
Rice MichaelPresident & CEOApr 16Option Exercise1.126,6407,437146,157Apr 18 04:22 PM
Rice MichaelPresident & CEOApr 16Sale7.156,64047,476139,517Apr 18 04:22 PM
GIRSCHWEILER THOMASDirectorApr 09Sale5.261,025,0005,391,5001,799,677Apr 10 07:26 PM
Rice MichaelPresident & CEOMar 15Option Exercise1.1212,54014,045152,057Mar 16 04:30 PM
Rice MichaelPresident & CEOMar 15Sale5.2712,54066,086139,517Mar 16 04:30 PM
Rice MichaelPresident & CEOFeb 15Option Exercise1.1212,54014,045152,057Feb 16 07:09 PM
Rice MichaelPresident & CEOFeb 15Sale5.2612,54065,960139,517Feb 16 07:09 PM
open in yahoo | open in reuters | open in google